The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Serotonin–dopamine interaction: electrophysiological evidence
Abstract
In this review, the most relevant data regarding serotonin (5-hydroxytryptamine, 5-HT)/dopamine (DA) interaction in the brain, as studied by both in vivo and in vitro electrophysiological methods, are reported and discussed. The bulk of neuroanatomical data available clearly indicate that DA-containing neurons in the brain receive a prominent innervation from 5-HT originating in the raphe nuclei of the brainstem. Furthermore, this modulation seems to be reciprocal; DA neurons innervate the raphe nuclei and exert a tonic excitatory effect on them. Compelling electrophysiological data show that 5-HT can exert complex effects on the electrical activity of midbrain DA neurons mediated by the various receptor subtypes. The main control seems to be inhibitory, this effect being more marked in the ventral tegmental area (VTA) as compared to the substantia nigra pars compacta (SNc). In spite of a direct effect of 5-HT by its receptors located on DA cells, 5-HT can modulate their activity indirectly, modifying gamma-amino-n-butyric acid (GABA)-ergic and glutamatergic input to the VTA and SNc. Although 5-HT/DA interaction in the brain has been extensively studied, much work remains to be done to clarify this issue. The recent development of subtype-selective ligands for 5-HT receptors will not only allow a detailed understanding of this interaction but also lead to development of new treatment strategies, appropriate for those neuropsychiatric disorders in which an alteration of the 5-HT/DA balance is supposed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Serotonergic and dopaminergic markers are jointly present in their developmental origins, guidepost areas, as well as within the subdomains of the PFC, which is important for their intricate interaction later in life to establish higher cognitive functions [209, 232–234].”
From Development of prefrontal cortex (2022) · cites this paper as [233]
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,211
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
Steinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415
Azmitia, E. C., & Segal, M. (1978) · The Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,908
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,898
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Evidence for the existence of monoamine neurons in the central nervous system
Fuxé, K. (1965) · Cell and Tissue Research · doi:10.1007/bf00337069 · Cited by 1,567
Fuxé, K. (1965) · PubMed · Cited by 1,544
The control of firing pattern in nigral dopamine neurons: burst firing
Grace, A., & Bunney, B. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-11-02877.1984 · Cited by 1,346
Efferent connections of the substantia nigra and ventral tegmental area in the rat
Beckstead, R. M., Domesick, V. B., & Nauta, W. J. H. (1979) · Brain Research · doi:10.1016/0006-8993(79)91001-1 · Cited by 1,293
DOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
Bunney, B. S., Walters, J. R., Roth, R. H., & Aghajanian, G. K. (1973) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29539-8 · Cited by 1,283
Svensson, T. H., Bunney, B. S., & Aghajanian, G. K. (1975) · Brain Research · doi:10.1016/0006-8993(75)90276-0 · Cited by 1,015
Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90135-5 · Cited by 937
Pompeiano, M., Palacios, J. M., & Mengod, G. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90223-2 · Cited by 870
Uniform Inhibition of Dopamine Neurons in the Ventral Tegmental Area by Aversive Stimuli
Ungless, M. A., Magill, P. J., & Bolam, J. P. (2004) · Science · doi:10.1126/science.1093360 · Cited by 782
Serotonin receptors in the human brain—III. Autoradiographic mapping of serotonin-1 receptors
Pazos, Á., Probst, A., & Palacios, J. M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90326-5 · Cited by 684
Molecular biology of 5-HT receptors
Boess, F., & Martin, I. L. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90059-0 · Cited by 675
Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain
Wright, D. E., Seroogy, K. B., Lundgren, K. H., Davis, B. M., & Jennes, L. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903510304 · Cited by 548
Aghajanian, G. K., & Bunney, B. S. (1977) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508803 · Cited by 548
Margolis, E. B., Lock, H., Hjelmstad, G. O., & Fields, H. L. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.117069 · Cited by 527
Mansour, A., Meador‐Woodruff, J. H., Bunzow, J., Civelli, O., Akil, H., & Watson, S. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-08-02587.1990 · Cited by 467
Bunney, B. S., Aghajanian, G. K., & Roth, R. H. (1973) · Nature New Biology · doi:10.1038/newbio245123a0 · Cited by 434
Serotonin content of the brain stem nuclei in the rat
Palkovits, M., Brownstein, M., & Saavedra, J. M. (1974) · Brain Research · doi:10.1016/0006-8993(74)90688-x · Cited by 384
Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS
Clemett, D. A., Punhani, T., Duxon, M. S., Blackburn, T. P., & Fone, K. C. F. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00086-6 · Cited by 373
Hervé, D., Pickel, V. M., JOH, T. H., & Beaudet, A. (1987) · Brain Research · doi:10.1016/0006-8993(87)91588-5 · Cited by 372
Bruinvels, A. T., Landwehrmeyer, G. B., Gustafson, E. L., Durkin, M. M., Mengod, G., Branchek, T. A., Hoyer, D., & Palacios, J. M. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90067-1 · Cited by 350
κ opioids selectively control dopaminergic neurons projecting to the prefrontal cortex
Margolis, E. B., Lock, H., Chefer, V. I., Shippenberg, T. S., Hjelmstad, G. O., & Fields, H. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511159103 · Cited by 326
Grace, A. A., & Bunney, B. S. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24386-5 · Cited by 315
Guiard, B. P., Mansari, M. E., Merali, Z., & Blier, P. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008383 · Cited by 307
Receptors for 5-Hydroxytryptamine: Current perspectives on classification and nomenclature
Martin, G. R., & Humphrey, P. P. A. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90058-2 · Cited by 305
Hoyer, D., Pazos, Á., Probst, A., & Palacios, J. M. (1986) · Brain Research · doi:10.1016/0006-8993(86)90903-0 · Cited by 291
Díaz-Mataix, L., Scorza, M. C., Bortolozzi, A. A., Tóth, M., Celada, P., & Artigas, F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2999-05.2005 · Cited by 288
Evidence for the existence of a raphe projection to the substantia nigra in rat
Dray, A., Gonye, T. J., Oakley, N. R., & Tanner, T. (1976) · Brain Research · doi:10.1016/0006-8993(76)90005-6 · Cited by 284
Ugedo, L., Grenhoff, J., & Svensson, T. H. (1989) · Psychopharmacology · doi:10.1007/bf00442004 · Cited by 268
Sorensen, S. M., Kehne, J. H., Fadayel, G. M., Humphreys, T. M., Ketteler, H., Sullivan, C. K., Taylor, V. L., & Schmidt, C. J. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38366-7 · Cited by 258
Matteo, V. D., Giovanni, G. D., Mascio, M. D., & Esposito, E. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00047-7 · Cited by 251
Self-citation5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons
Johnson, S., Mercuri, N. B., & North, R. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-05-02000.1992 · Cited by 245
Abramowski, D., Rigo, M., Duc, D., Hoyer, D., & Staufenbiel, M. (1995) · Neuropharmacology · doi:10.1016/0028-3908(95)00138-7 · Cited by 243
Grace, A. A., & Bunney, B. S. (1980) · Science · doi:10.1126/science.7433992 · Cited by 241
Mengod, G., Pompeiano, M., ́nez-Mir, M. I. M., & Palacios, J. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90502-3 · Cited by 240
Lavoie, B. A., & Parent, A. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902990102 · Cited by 239
Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90136-7 · Cited by 235
Chiodo, L. A. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80073-3 · Cited by 234
Role of 5-HT2C receptors in the control of central dopamine function
Matteo, V. D., Blasi, A. D., Giulio, C. D., & Esposito, E. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01688-6 · Cited by 233
Self-citationD3 dopamine receptor mRNA is widely expressed in the human brain
Suzuki, M., Hurd, Y. L., Sokoloff, P., Schwartz, J.-C., & Sedvall, G. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01078-0 · Cited by 232
Morilak, D. A., Garlow, S. J., & Ciaranello, R. D. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90241-7 · Cited by 231
Sakai, K., Salvert, D., Touret, M., & Jouvet, M. (1977) · Brain Research · doi:10.1016/0006-8993(77)91010-1 · Cited by 226
Mengod, G., Nguyen, H., Le, H., Waeber, C., Lübbert, H., & Palacios, J. M. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90330-7 · Cited by 226
Fahn, S., Libsch, L. R., & Cutler, R. W. P. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90178-x · Cited by 224
Porras, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00333-5 · Cited by 222
Sari, Y., Miquel, M., Brisorgueil, M., Ruiz, G., Doucet, E., Hamon, M., & Vergé, D. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00256-5 · Cited by 222
Felder, C. C., Kanterman, R. Y., Ma, A. L., & Axelrod, J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.6.2187 · Cited by 220
Giovanni, G. D., Deurwaerdère, P. D., Mascio, M. D., Matteo, V. D., Esposito, E., & Spampinato, U. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00655-1 · Cited by 219
Self-citationPrisco, S., Pagannone, S., & Esposito, E. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22843-9 · Cited by 214
Self-citationFibiger, H. C., & Miller, J. J. (1977) · Neuroscience · doi:10.1016/0306-4522(77)90120-8 · Cited by 213
Duxon, M. S., Flanigan, T. P., Reavley, A. C., Baxter, G. S., Blackburn, T. P., & Fone, K. C. F. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00480-0 · Cited by 210
Dray, A., Davies, J. I., Oakley, N. R., Tongroach, P., & Vellucci, S. V. (1978) · Brain Research · doi:10.1016/0006-8993(78)91077-6 · Cited by 209
Chiodo, L. A., & Bunney, B. (1985) · Journal of Neuroscience · doi:10.1523/jneurosci.05-09-02539.1985 · Cited by 196
Bockstaele, E. J. V., & Pickel, V. M. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903340408 · Cited by 196
A novel strategy for the treatment of cocaine addiction
Dewey, S. L., Morgan, A. E., Ashby, C. R., Horan, B., Kushner, S. A., Logan, J., Volkow, N. D., Fowler, J. S., Gardner, E. L., & Brodie, J. D. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199810)30:2 · Cited by 194
Cocaine inhibits GABA release in the VTA through endogenous 5-HT
Cameron, D., & Williams, J. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-11-06763.1994 · Cited by 188
Matteo, V. D., Giovanni, G. D., Mascio, M. D., & Esposito, E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02246-0 · Cited by 184
Self-citationPrisco, S., & Esposito, E. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16684.x · Cited by 181
Self-citationDoherty, M. D., & Pickel, V. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02062-x · Cited by 178
Sinton, C. M., & Fallon, S. L. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90380-9 · Cited by 174
Kelland, M. D., Freeman, A. S., & Chiodo, L. A. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13049-8 · Cited by 171
Localization of 5-HT2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group
Nocjar, C., Roth, B. L., & Pehek, E. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00593-0 · Cited by 169
Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra
Nedergaard, S., Bolam, J. P., & Greenfield, S. A. (1988) · Nature · doi:10.1038/333174a0 · Cited by 166
Arborelius, L., Chergui, K., Murase, S., Nomikos, G. G., H��k, B. B., Chouvet, G., Hacksell, U., & Svensson, T. H. (1993) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165384 · Cited by 165
A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids
Cameron, D., Wessendorf, M. W., & Williams, J. T. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00444-7 · Cited by 163
Distribution of serotonin 5-HT2C receptors in the ventral tegmental area
Bubar, M. J., & Cunningham, K. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.071 · Cited by 162
Liu, S., Bubar, M. J., Lanfranco, M. F., Hillman, G. R., & Cunningham, K. A. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.064 · Cited by 159
Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade
Cremers, T. I. F. H., Giorgetti, M., Bosker, F. J., Hogg, S., Arnt, J., Mørk, A., Honig, G., Bøgesø, K.-P., Westerink, B. H. C., den Boer, H., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300474 · Cited by 157
Ji, S., Zhang, Y., Cleemput, J. V., Jiang, W., Liao, M., Li, L., Wan, Q., Backstrom, J. R., & Zhang, X. (2006) · Nature Medicine · doi:10.1038/nm1349 · Cited by 156
Pasqualetti, M., Ori, M., Castagna, M., Marazziti, D., Cassano, G. B., & Nardi, I. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00011-1 · Cited by 154
Moukhles, H., Bosler, O., Bolam, J. P., Vallée, A., Umbriaco, D., Geffard, M., & Doucet, G. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00452-6 · Cited by 151
Lacroix, L. P., Dawson, L. A., Hagan, J. J., & Heidbreder, C. A. (2003) · Synapse · doi:10.1002/syn.10288 · Cited by 150
Marquis, K. L., Sabb, A. L., Logue, S. F., Brennan, J. A., Piesla, M. J., Comery, T. A., Grauer, S. M., Ashby, C. R., Nguyen, H. Q., Dawson, L. A., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106989 · Cited by 145
Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro
Pessia, M., Jiang, Z., North, R. A., & Johnson, S. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)90495-2 · Cited by 138
Barnes, J. M., Barnes, N. M., Champaneria, S., Costall, B., & Naylor, R. J. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90110-d · Cited by 131
Bockstaele, E. J. V., Cestari, D. M., & Pickel, V. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91330-7 · Cited by 126
Giovanni, G. D., Matteo, V. D., Grutta, V. L., & Esposito, E. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00561-3 · Cited by 125
Self-citationPhysiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors
Berg, K. A., Harvey, J. A., Spampinato, U., & Clarke, W. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.10.008 · Cited by 111
Gervais, J., & Rouillard, C. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000315)35:4 · Cited by 109
�sterlund, M. K., Halldin, C., & Hurd, Y. L. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1 · Cited by 108
Self-citationJones, S., & Kauer, J. A. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-22-09780.1999 · Cited by 102
Aman, T. K., Shen, R., & Haj‐Dahmane, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111690 · Cited by 102
Distribution of serotonin and synthesizing enzymes in discrete areas of the brain.
Saavedra, J. M. (1977) · PubMed · Cited by 102
Ultrastructure and synaptic targets of the raphe-nigral projection in the rat
Corvaja, N., Doucet, G., & Bolam, J. P. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90510-m · Cited by 101
REGIONAL DISTRIBUTION OF MONOAMINES AND THEIR METABOLITES IN THE HUMAN BRAIN
Mackay, A. V. P., Yates, C. M., Wright, A., Hamilton, P., & Davies, P. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb10792.x · Cited by 98
Invernizzi, R. W., Pierucci, M., Calcagno, E., Giovanni, G. D., Matteo, V. D., Benigno, A., & Esposito, E. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.004 · Cited by 95
Self-citationAndersson, J. L., Nomikos, G. G., Marcus, M. M., Hertel, P., Mathé, J. M., & Svensson, T. H. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00172774 · Cited by 92
D2‐like dopamine receptor activation excites rat dorsal raphe 5‐HT neurons in vitro
Haj‐Dahmane, S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01616.x · Cited by 92
Sorensen, S. M., Humphreys, T. M., & Palfreyman, M. G. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90402-0 · Cited by 92
Brodie, M. S., Trifunovic, R., & Shefner, S. A. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09580-1 · Cited by 89
Ferré, S., & Artigas, F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb02187.x · Cited by 87
Waeber, C., & PALACIOS, J. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90082-1 · Cited by 85
Central Serotonin2C Receptor: From Physiology to Pathology
Giovanni, G. D., Matteo, V. D., Pierucci, M., Benigno, A., & Esposito, E. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606778522113 · Cited by 85
Self-citationAugmentation of SSRI Effects on Serotonin by 5-HT2C Antagonists: Mechanistic Studies
Cremers, T. I. F. H., Rea, K., Bosker, F. J., Wikström, H., Hogg, S., Mørk, A., & Westerink, B. H. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301287 · Cited by 83
Kal�n, P., Skagerberg, G., & Lindvall, O. (1988) · Experimental Brain Research · doi:10.1007/bf00279662 · Cited by 81
Distribution of dopamine-immunoreactive fibers in the rat brainstem
Kitahama, K., Nagatsu, I., Geffard, M., & Maeda, T. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(99)00047-2 · Cited by 79
Ascending afferent regulation of rat midbrain dopamine neurons
Kelland, M. D., Freeman, A. S., Rubin, J. R., & Chiodo, L. A. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90121-q · Cited by 77
Maj, J., & Moryl, E. (1992) · Journal of Neural Transmission · doi:10.1007/bf01244819 · Cited by 73
Martín‐Ruiz, R., Ugedo, L., Honrubia, M., Mengod, G., & Artigas, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00275.x · Cited by 72
Liu, Z., Bunney, E. B., Appel, S. B., & Brodie, M. S. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00281.2003 · Cited by 70
Excitatory actions of serotonin on GABAergic neurons of the medial septum and diagonal band of broca
Alreja, M. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199601)22:1 · Cited by 67
Boothman, L. J., Mitchell, S. N., & Sharp, T. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.020 · Cited by 67
Trent, F., & Tepper, J. M. (1991) · Experimental Brain Research · doi:10.1007/bf00230974 · Cited by 65
Mori, S., Matsuura, T., Takino, T., & Sano, Y. (1987) · Anatomy and Embryology · doi:10.1007/bf00309747 · Cited by 65
Doherty, M. D., & Pickel, V. M. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1147 · Cited by 63
Rasmussen, K., Stockton, M. E., & Czachura, J. F. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90781-k · Cited by 58
Presynaptic dopamine D4 receptor localization in the rat nucleus accumbens shell
Svingos, A. L., Periasamy, S., & Pickel, V. M. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000601)36:3 · Cited by 58
Publisher, B. S. P. B. S. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706778521805 · Cited by 56
Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration
Ikemoto, K., Nishimura, A., Okado, N., Mikuni, M., Nishi, K., & Nagatsu, I. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02237-4 · Cited by 56
Lucas, G., Matteo, V. D., Deurwaerdère, P. D., Porras, G., Martín‐Ruiz, R., Artigas, F., Esposito, E., & Spampinato, U. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01453.x · Cited by 55
Self-citationPierucci, M., Matteo, V. D., & Esposito, E. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062208 · Cited by 53
Self-citationSerotonin‐1B receptor‐mediated inhibition of [3H]GABA release from rat ventral tegmental area slices
Yan, Q., & Yan, S. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00643.x · Cited by 50
Porras, G., Matteo, V. D., Deurwaerdère, P. D., Esposito, E., & Spampinato, U. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00212-5 · Cited by 50
Self-citationSekine, Y., Suzuki, K., Ramachandran, P. V., Blackburn, T. P., & Ashby, C. R. (2007) · Synapse · doi:10.1002/syn.20349 · Cited by 49
Wirtshafter, D., Stratford, T. R., & Asin, K. E. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90509-x · Cited by 48
Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro
Brodie, M. S., & Bunney, E. B. (1996) · Journal of Neurophysiology · doi:10.1152/jn.1996.76.3.2077 · Cited by 46
Minabe, Y., Ashby, C. R., Schwartz, J. E., & Wang, R. Y. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90162-j · Cited by 45
Minabe, Y., Shirayama, Y., Hashimoto, K., Routledge, C. A., Hagan, J. J., & Ashby, C. R. (2004) · Synapse · doi:10.1002/syn.20002 · Cited by 44
Distribution and characterization of [3H]mesulergine binding in human brain postmortem
Marazziti, D., Rossi, A., Giannaccini, G., Zavaglia, K. M., Dell’Osso, L., Lucacchini, A., & Cassano, G. B. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00045-0 · Cited by 44
Olijslagers, J. E., Werkman, T. R., McCreary, A. C., Kruse, C. G., & Wadman, W. J. (2005) · Current Neuropharmacology · doi:10.2174/157015906775203020 · Cited by 42
Berretta, N., Freestone, P. S., Guatteo, E., de Castro, D., Geracitano, R., Bernardi, G., Mercuri, N. B., & Lipski, J. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.01.014 · Cited by 42
Slow Oscillatory Firing: A Major Firing Pattern of Dopamine Neurons in the Ventral Tegmental Area
Shi, W. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00317.2005 · Cited by 42
Comparison of projections of the dorsal and median raphe nuclei, with some functional considerations
Vertes, R. P., & Linley, S. B. (2007) · International Congress Series · doi:10.1016/j.ics.2007.07.046 · Cited by 39
Olijslagers, J. E., Werkman, T. R., McCreary, A. C., Siarey, R. J., Kruse, C. G., & Wadman, W. J. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.003 · Cited by 38
Bunney, E. B., Appel, S. B., & Brodie, M. S. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39246-8 · Cited by 38
5-HT3 and 5-HT4 receptors in terminal regions of the mesolimbic system
Kilpatrick, G. J., Hagan, R. M., & Gale, J. D. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00063-0 · Cited by 37
Zacopride in Schizophrenia: A Single-blind Serotonin Type 3 Antagonist Trial
Faustman, W. O. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090079013 · Cited by 37
Decavel, C., Lescaudron, L., Mons, N. E., & Calas, A. (1987) · Journal of Histochemistry & Cytochemistry · doi:10.1177/35.11.3309046 · Cited by 35
Blackburn, T. P., Minabe, Y., Middlemiss, D. N., Shirayama, Y., Hashimoto, K., & Ashby, C. R. (2002) · Synapse · doi:10.1002/syn.10116 · Cited by 32
Shi, W. X., Nathaniel, P., & Bunney, B. S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10609-5 · Cited by 31
Nie, F., & Wong‐Riley, M. T. T. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960701)370:3 · Cited by 30
Blier, P. U., de Montigny, C., & Azzaro, A. J. (1986) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00508779 · Cited by 29
Ashby, C. R., Jiang, L. H., & Wang, R. Y. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90574-p · Cited by 28
Cameron, D., & Williams, J. (1995) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1995.tb01947.x · Cited by 28
Minabe, Y., Hashimoto, K., Watanabe, K., & Ashby, C. R. (2001) · Synapse · doi:10.1002/syn.1031 · Cited by 27
Prisco, S., Pessia, M., Ceci, A., Borsini, F., & Esposito, E. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90089-m · Cited by 25
Self-citationIntracellular 5-HT2C-receptor dephosphorylation: a new target for treating drug addiction
Müller, C. P., & Carey, R. J. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.003 · Cited by 25
Trifunovic, R., & Brodie, M. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12271-4 · Cited by 24
Mascio, M. D., & Esposito, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00108-5 · Cited by 23
Self-citationBrain monoamines in the rhesus monkey during long-term neuroleptic administration.
Shannak, K. S., & Hornykiewicz, O. (1980) · PubMed · Cited by 22
Paolucci, E., Berretta, N., Tozzi, A., Bernardi, G., & Mercuri, N. B. (2003) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2003.03015.x · Cited by 20
Will it Ever Become Possible to Prevent Dopaminergic Neuronal Degeneration?
Giovanni, G. D. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708783885192 · Cited by 18
Zhang, Q.-J., Gao, R., Liu, J., Liu, Y.-P., & Wang, S. (2007) · PubMed · Cited by 17
Mnie‐Filali, O., Dahan, L., Zimmer, L., & Haddjeri, N. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.037 · Cited by 14
Chu, Y., Liu, J., Feng, J., Wang, Y., Zhang, Q.-J., & Li, Q. (2004) · PubMed · Cited by 10
Role of central 5-HT2C receptor in the control of basal ganglia functions
Esposito, E., Matteo, V. D., Pierucci, M., Benigno, A., & Giovanni, G. D. (2007) · OAR@UM (University of Malta) · Cited by 5
Self-citationCornea-Hébert (1999) · doi:10.1002/(sici)1096-9861(19990628)409:2
Cited by
Sorted by citations
International society of sports nutrition position stand: caffeine and performance
Goldstein, E. R., Ziegenfuss, T., Kalman, D., Kreider, R., Campbell, B., Wilborn, C., Taylor, L., Willoughby, D., Stout, J., Graves, B. S., et al. (2010) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-7-5 · Cited by 686
International Society of Sports Nutrition Position Stand: Caffeine and Exercise Performance
Guest, N. S., VanDusseldorp, T. A., Nelson, M. T., Grgic, J., Schoenfeld, B. J., Jenkins, N. D. M., Arent, S. M., Antonio, J., Stout, J. R., Trexler, E. T., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-020-00383-4 · Cited by 665
Development of prefrontal cortex
Kolk, S. M., & Rakic, P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01137-9 · Cited by 378
VLAAMS DIERGENEESKUNDIG TIJDSCHRIFT
Vermeire, S., Audenaert, K., Vandermeulen, E., Mees, R. D., van Bree, H., Dobbeleir, A. A., Peremans, K. Y., De, R., Declercq, A., Maes, S., et al. (2011) · Cited by 297
Hale, M. W., Shekhar, A., & Lowry, C. A. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9827-1 · Cited by 220
Metadata
- Authors
- DIGIOVANNI, G., DIMATTEO, V, PIERUCCI, M., & ESPOSITO, E.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Corresponding author
- ESPOSITO, E
- ORCID
- PIERUCCI, M
- Venue
- Progress in Brain Research
- Publisher
- Elsevier
- Published
- 2008
- Volume
- 172
- Pages
- 45-71
- ISSN
- 0079-6123 (ISSN-L)
- OpenAlex
- W1554279409
- Cited by
- 151
- References
- 153
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 6 · 2019: 10 · 2018: 7 · 2017: 5 · 2016: 10 · 2015: 9 · 2014: 15 · 2013: 10 · 2012: 10
- FWCI
- 12.85
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Progress in brain research (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- serotonin-dopamine interaction, serotonin, dopaminergic neurons, raphe nuclei, ventral tegmental area, substantia nigra pars compacta, serotonin receptors, GABAergic input, glutamatergic input, neuropsychiatric disorders, subtype-selective ligands
- MeSH terms
- Animals, Brain, Dopamine, Electric Stimulation, Electrophysiology, Neural Pathways, Neurons, Receptors, Serotonin, Serotonin, Serotonin Antagonists, Serotonin Receptor Agonists, Selective Serotonin Reuptake Inhibitors, Dopamine Agonists, Dopamine Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review